Compare Trip.com Group Ltd (TCOM) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Trip.com Group Ltd vs DENTSPLY SIRONA Inc — how do they compare? Trip.com Group Ltd trades at $39.31 (market cap $26.04B), while DENTSPLY SIRONA Inc trades at $10.68 (market cap $2.19B). The key difference: Trip.com Group Ltd is far larger — about 11.9× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals.
| TCOM | XRAY | |
|---|---|---|
Market Cap | $26.04B | $2.19B |
Sector | Consumer Cyclical | Health |
52-Week High | $78.96 | $14.68 |
52-Week Low | $39.19 | $9.64 |
Enterprise Value | $18.64B | $4.26B |
Dividend Yield | 0.42% | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Trip.com (TCOM) trades at $40.50, down 1.29% with bearish technical signals despite strong fundamentals. The company reported robust 2025 results with $62.41B revenue and 53.34% net margin, though recent quarters show earnings misses. Valuation metrics appear attractive with P/E of 6.01 and EV/EBITDA of 3.21. However, the stock faces headwinds from a recent $770M Chinese antitrust penalty and declining cash flow trends.
The investment case balances deep value against regulatory risks. Analyst consensus remains bullish with $59.29 price target (47% upside), but technical weakness and China regulatory overhang create near-term uncertainty. Long-term growth prospects in travel recovery support the bull case, though investors should monitor Q2 2026 earnings due September 15 for confirmation of business momentum.
XRAY trades at $10.99, down 3.43% on the day, reflecting ongoing challenges amid a bearish technical signal. The company reported a Q2 2026 earnings beat but faces declining revenue and negative profitability, with a net income margin of -14.99%. Cash flow trends show volatility, and the debt-to-asset ratio has worsened to 42.88% in 2025. Recent news highlights margin pressure and a class-action lawsuit inquiry, clouding the near-term outlook despite some institutional buying interest.
The investment outlook is cautious. While the stock trades below the consensus price target of $12.50, persistent net losses, high debt, and competitive pressures pose significant risks. Analyst sentiment is mixed with a 'Hold' consensus, suggesting limited upside until the company demonstrates sustained operational improvement and revenue stabilization.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
